GLP-1 药物对肥胖青少年是否实用且安全?
Are GLP-1s practical and safe for adolescents with obesity?
美国佐治亚大学研究者基于一篇发表于《Appetite》的综述接受访谈,讨论 GLP-1 药物用于肥胖青少年的适用性与安全性疑问。原文提到 FDA 与儿科学会均已批准部分 GLP-1 用于 12 岁及以上、生活方式干预后仍持续肥胖的青少年,研究者称这类药物可帮助青少年减掉最多 15% 的体重。研究者指出长期影响尚不清楚,需关注大脑发育、肌肉流失和停药后体重反弹,并强调预防与日常身体活动。
GLP-1 medications have become a popular tool for weight loss. But are they appropriate for all age groups? Short for glucagon-like peptide-1, GLP-1s are medications approved by the Food and Drug Administration that treat type 2 diabetes and now obesity. They work by mimicking a natural hormone in the gut that lowers blood sugar, simulates the feeling of fullness and slows digestion.
Both the American Academy of Pediatrics and the FDA have approved certain GLP-1s for youth ages 12 and older who experience persistent obesity after a trial of lifestyle modification. However, a new review from the University of Georgia published in the journal Appetite suggests there is still uncertainty about how the drugs may impact adolescent development, both physically and mentally.
Emily Noble, a nutritional neuroscientist and associate professor in the UGA College of Family and Consumer Sciences, answers some of the most pressing questions about the popular drug and what science says about its use in children.
Why are GLP-1s used as a possible intervention for youth with obesity?
Adolescents with obesity are more likely to also have obesity during adulthood. Once obesity develops, it's very hard to reverse.
Despite what you may see in recommendations from TV and magazines, this idea that making different choices will promote sustained weight loss is not correct, and the data back that up.
The brain is what governs body weight, and there is evidence to support that once obesity develops, the brain regulates body weight differently and this makes it difficult to lose weight and keep it off without medical intervention.
There's a biological drive toward weight regain following weight loss. I think people think about obesity as just a matter of decisions or self-control. But we know that there are neurobiological things that occur that are beyond conscious control that regulate body weight.
How are GLP-1s currently used in adolescents?
GLP-1s are typically extreme interventions for adolescent obesity and are only considered when other options fail.
This is the case for most clinicians who work with adolescents with true, severe obesity. They have high levels of body fat, so the deleterious effects of obesity outweigh the potential negative risks of GLP-1s. These drugs can help kids lose up to 15% of their body weight.
The medications are actively being used in youth. They're approved for 12-year-olds and older, but sometimes people are prescribing them even younger in special circumstances because we're starting to see obesity and prediabetes earlier and earlier in kids.
What are some of the potential risks associated with GLP-1s in this age group?
It will be a long time before we know what the long-term effects of the medications are in this group, but the main question that we have right now is what happens to adolescents during this sensitive period of development?
These medications impact the brain by affecting the sensitivity of different circuits that make you want to eat or not, so how does that change the way their brains develop?
When these medications cause weight loss, are these kids also losing muscle mass?
Those are also important questions, especially when you consider puberty.
Youth is also kind of a volatile age range. Everything they experience is more likely to be amplified.
When it comes to the behavioral modification that these medications could have and if adolescents lose weight and then gain weight and then lose weight and then gain weight, they could end up in a worse situation than if they never did take the medication to begin with.
What should parents consider in allowing their child to take GLP-1s?
I do think that parents should listen to their doctors, but a second opinion never hurts.
GLP-1s can be very useful tools, but it's also important to know that weight often rebounds when you go off the medication.
We know that obesity can also have long-term effects on brain function and susceptibility to metabolic diseases, cancer and a bunch of other things, so it is important to weigh all options.
What are alternative ways to combat childhood obesity?
Prevention is definitely where the solution has been for a long time. Exercise doesn't always help people lose weight, but it's great for weight loss maintenance, for preventing weight gain and for metabolic health.
Getting kids more opportunities to have activity in their lives, to move more in general, should be a big goal. Reducing the screen time is good, but getting them to just be more naturally active is better.
Also, modeling healthy eating patterns for kids from an early age is great for obesity prevention. Cook with your kids, have dinner with your kids and choose a healthy, balanced diet.
Publication details
Austin M. Mills et al., GLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period, Appetite (2026). DOI: 10.1016/j.appet.2026.108729
Journal information: Appetite
Key medical concepts
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Are GLP-1s practical and safe for adolescents with obesity? (2026, October 27) retrieved 27 October 2026 from https://medicalxpress.com/news/2026-10-glp-1s-safe-adolescents-obesity.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com